MAM
Zee announces first bunch of ‘India’s Best’ talents
MUMBAI: India’s Best – Cinestar Ki Khoj received good response in the first four cities where it was held; Hyderabad, Ahmedabad, Kanpur and Lucknow, with participants queuing up at the audition venue, all vying to try their chance to be the next big cine-star of Bollywood.
Speaking on the occasion Zee TV president Sunil Khanna said, “We had expected an immense response. But what we witnessed in the first four cities was overwhelming. All the four centers have made us very bullish about the expected response in the other cities. The talent that exists in our country is enough to make anyone proud.”
After choosing the best from Hyderabad, Ahmedabad, Kanpur, Lucknow, Cinestar ki khoj moves to the next set of cities Bhopal, Baroda, Jaipur and Bangalore. The auditions in these cities started yesterday and the finalist will be chosen in the final event on the 26 May.
The big break for the excited young Mumbaikars will start on 2 June with auditions taking place at SNDT University Juhu Mumbai.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
